{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:40:26Z","timestamp":1790822426950,"version":"4.1.0"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:00:00Z","timestamp":1568246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02150","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:27:19Z","timestamp":1568248039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action"],"prefix":"10.3389","volume":"10","author":[{"given":"Paul R.","family":"Buckley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Alden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Chalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane T.","family":"Temmerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud M.","family":"Didierlaurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert","family":"van der Most","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Timmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus A.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C.","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,9,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immun"},{"key":"B2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nm.3083","article-title":"Immune mechanisms in malaria: new insights in vaccine development","volume":"19","author":"Riley","year":"2013","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing \u03b1-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fimmu.2016.00427","article-title":"Modulation of primary immune response by different vaccine adjuvants","volume":"7","author":"Ciabattini","year":"2016","journal-title":"Front Immun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/17425247.2016.1151871","article-title":"Liposomal adjuvants for human vaccines","volume":"5247","author":"Alving","year":"2016","journal-title":"Expert Opin Drug Deliv"},{"key":"B7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1099\/jmm.0.038943-0","article-title":"Alum adjuvant: some of the tricks of the oldest adjuvant","volume":"61","author":"Kool","year":"2012","journal-title":"J Med Microbiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"B10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/1060028018758431","article-title":"Shingrix: the new adjuvanted recombinant herpes zoster vaccine","volume":"57","author":"James","year":"2018","journal-title":"Ann Pharmacother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01 EVaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/09680519060120050701","article-title":"TLR4 agonists as immunomodulatory agents","volume":"12","author":"Alderson","year":"2006","journal-title":"J Endotoxin Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.coi.2016.06.007","article-title":"The science of vaccine adjuvants: advances in TLR4 ligand adjuvants","volume":"41","author":"Reed","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6186","DOI":"10.4049\/jimmunol.0901474","article-title":"AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity","volume":"183","author":"Didierlaurent","year":"2009","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1016\/j.vaccine.2016.03.016","article-title":"Synthetic TLR4 agonists enhance functional antibodies and CD4+ T-cell responses against the Plasmodium falciparum GMZ2","volume":"34","author":"Baldwin","year":"2016","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1038\/srep39475","article-title":"Central role of CD169+ lymph node resident macrophages in the adjuvanticity of the QS-21 component of AS01","volume":"6","author":"Detienne","year":"2016","journal-title":"Sci Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1074\/jbc.M115.683011","article-title":"Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants","volume":"291","author":"Marty-Roix","year":"2016","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4049\/jimmunol.176.2.1203","article-title":"A potent adjuvant monophosphoryl lipid A triggers various immune responses, but not secretion of IL-1beta or activation of caspase-1","volume":"176","author":"Okemoto","year":"2006","journal-title":"J Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.vaccine.2014.10.078","article-title":"Vaccine adjuvant systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination","volume":"33","author":"Leroux-Roels","year":"2015","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3389\/fimmu.2017.00557","article-title":"Predicting RTS,S vaccine-mediated protection from transcriptomes in a malaria-challenge clinical trial","volume":"8","author":"van den Berg","year":"2017","journal-title":"Front Immun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","article-title":"Inflammasome complexes: emerging mechanisms and effector functions","volume":"165","author":"Rathinam","year":"2016","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.cell.2012.07.021","article-title":"A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread","volume":"150","author":"Kastenm\u00fcller","year":"2012","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1105\/tpc.106.042267","article-title":"Every object that biology studies is a system of systems. Francois Jacob","volume":"18","author":"Trewavas","year":"2006","journal-title":"Plant Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.phrs.2014.08.006","article-title":"Computational modelling approaches to vaccinology","volume":"92","author":"Pappalardo","year":"2015","journal-title":"Pharmacol Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jtbi.2011.06.037","article-title":"Systems biology approaches for understanding cellular mechanisms of immunity in lymph nodes during infection","volume":"287","author":"Mirsky","year":"2011","journal-title":"J Theor Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.coisb.2017.05.014","article-title":"A review of computational and mathematical modeling contributions to our understanding of Mycobacterium tuberculosis within-host infection and treatment","volume":"3","author":"Kirschner","year":"2017","journal-title":"Curr Opin Syst Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fimmu.2012.00172","article-title":"Pairing experimentation and computational modeling to understand the role of tissue inducer cells in the development of lymphoid organs","volume":"3","author":"Alden","year":"2012","journal-title":"Front Immun"},{"key":"B31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/infdis\/jiw237","article-title":"Fractional third and fourth dose of RTS,S\/AS01 malaria candidate vaccine: a phase 2a controlled human malaria parasite infection and immunogenicity study","volume":"214","author":"Regules","year":"2016","journal-title":"J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.4049\/jimmunol.166.3.1951","article-title":"A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis","volume":"166","author":"Wigginton","year":"2001","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jtbi.2010.05.012","article-title":"TNF and IL-10 are major factors in modulation of the phagocytic cell environment in lung and lymph node in tuberculosis: A next-generation two-compartmental model","volume":"265","author":"Marino","year":"2010","journal-title":"J Theor Biol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/psp4.12018","article-title":"Agent-based modeling in systems pharmacology","volume":"4","author":"Cosgrove","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fimmu.2016.00658","article-title":"Model-driven experimentation: a new approach to understand mechanisms of tertiary lymphoid tissue formation, function, and therapeutic resolution","volume":"7","author":"Butler","year":"2017","journal-title":"Front Immun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3390\/computation3020222","article-title":"Computational approach to 3D modeling of the lymph node geometry","volume":"3","author":"Kislitsyn","year":"2015","journal-title":"Computation"},{"key":"B37","doi-asserted-by":"publisher","first-page":"158rv11","DOI":"10.1126\/scitranslmed.3003528","article-title":"Computational medicine: translating models to clinical care","volume":"4","author":"Winslow","year":"2012","journal-title":"Science Transl Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1039\/c0ib00075b","article-title":"Multi-scale modelling and simulation in systems biology","volume":"3","author":"Dada","year":"2011","journal-title":"Integr Biol (Camb)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1003334","DOI":"10.1371\/journal.pcbi.1003334","article-title":"A petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani Infection","volume":"9","author":"Albergante","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e80506","DOI":"10.1371\/journal.pone.0080506","article-title":"Determining disease intervention strategies using spatially resolved simulations","volume":"8","author":"Read","year":"2013","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1002916","DOI":"10.1371\/journal.pcbi.1002916","article-title":"Spartan: a comprehensive tool for understanding uncertainty in simulations of biological systems","volume":"9","author":"Alden","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"20141059","DOI":"10.1098\/rsif.2014.1059","article-title":"Using argument notation to engineer biological simulations with increased confidence","volume":"12","author":"Alden","year":"2015","journal-title":"J R Soc Interface"},{"key":"B43","doi-asserted-by":"publisher","first-page":"20140704","DOI":"10.1098\/rsif.2014.0704","article-title":"Modelling biological behaviours with the unified modelling language: an immunological case study and critique","volume":"11","author":"Read","year":"2014","journal-title":"J R Soc Interface"},{"key":"B44","unstructured":"AndrewsPS\n            PolackFAC\n            SampsonAT\n            StepneyS\n            TimmisJ\n          The CoSMoS Process, Version 0.1: A Process for the Modelling and Simulation of Complex Systems2010"},{"key":"B45","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11047-014-9428-7","article-title":"Utilising a simulation platform to understand the effect of domain model assumptions","volume":"14","author":"Alden","year":"2014","journal-title":"Nat Comput"},{"key":"B46","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nbt1558","article-title":"The systems biology graphical notation","volume":"27","author":"Le Novere","year":"2009","journal-title":"Nat Biotechnol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1478-5382(03)02370-9","article-title":"CellDesigner: a process diagram editor for gene-regulatory and biochemical networks","volume":"1","author":"Funahashi","year":"2003","journal-title":"BIOSILICO."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1073\/pnas.1215165110","article-title":"Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology","volume":"110","author":"Michaud","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.4049\/jimmunol.1600817","article-title":"The lymphatic immune response induced by the adjuvant AS01: a comparison of intramuscular and subcutaneous immunization routes","volume":"197","author":"Neeland","year":"2016","journal-title":"J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0092-8674(00)80059-8","article-title":"CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs","volume":"99","author":"F\u00f6rster","year":"1999","journal-title":"Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-540-71029-5_2","article-title":"Dendritic cell migration to peripheral lymph nodes","volume":"188","author":"Mart\u00edn-Fontecha","year":"2009","journal-title":"Handb Exp Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature06287","article-title":"Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells","volume":"450","author":"Junt","year":"2007","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/925135","article-title":"CD4 +T cells: differentiation and functions","volume":"2012","author":"Luckheeram","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1152\/physrev.00023.2001","article-title":"Dendritic cells: immune regulators in health and disease","volume":"82","author":"Lipscomb","year":"2002","journal-title":"Physiol Rev."}],"updated-by":[{"DOI":"10.3389\/fimmu.2019.02905","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T00:00:00Z","timestamp":1575244800000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T10:34:37Z","timestamp":1575282877000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,12]]},"references-count":54,"alternative-id":["10.3389\/fimmu.2019.02150"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02150","relation":{"erratum":[{"id-type":"doi","id":"10.3389\/fimmu.2019.02905","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,12]]},"article-number":"2150"}}